Aytu Biopharma (AYTU) EBITDA Margin Growth (1y) (2014 - 2026)
Powered by 
Analysis
Aytu Biopharma (AYTU) EBITDA Margin Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 22.00 |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 613.00 |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -3,510.00 |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -164.00 |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -611.00 |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | -572.00 |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | -194.00 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | -341.00 |
| 10 | Aytu Biopharma | 22.49 Mn | -4.22 Mn | 7.60 Mn | -4,587.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -4,587.00 |
| Dec 31, 2025 | -254.00 |
| Sep 30, 2025 | -522.00 |
| Jun 30, 2025 | -3,479.00 |
| Mar 31, 2025 | 2,451.00 |
| Dec 31, 2024 | -2,723.00 |
| Sep 30, 2024 | -75.00 |
| Jun 30, 2024 | -1,613.00 |
| Mar 31, 2024 | 2,626.00 |
| Dec 31, 2023 | 4,292.00 |
| Sep 30, 2023 | 167.00 |
| Jun 30, 2023 | 6,227.00 |
| Mar 31, 2023 | 18,311.00 |
| Dec 31, 2022 | 2,270.00 |
| Sep 30, 2022 | 11,996.00 |
| Jun 30, 2022 | 4,080.00 |
| Dec 31, 2021 | -1,203.00 |
| Sep 30, 2021 | -10,019.00 |
| Jun 30, 2021 | -5,786.00 |
| Dec 31, 2020 | 11,963.00 |